The Extra-Hematopoietic Role of Erythropoietin in Diabetes Mellitus

Author(s): Diana Choi, Ravi Retnakaran, Minna Woo

Journal Name: Current Diabetes Reviews

Volume 7 , Issue 4 , 2011

Become EABM
Become Reviewer


Diabetes mellitus is a complex metabolic disorder characterized by chronic hyperglycemia and vascular complications, leading to significant morbidity and mortality. All forms of diabetes are ultimately related to insufficient functional pancreatic β-cell mass to maintain euglycemia. In this context, the promotion of β-cell survival and function is a fundamental issue of direct relevance to diabetes prevention and treatment. Although first identified as a hematopoietic factor that promotes erythropoiesis and erythrocyte survival, an accumulating body of evidence suggests that erythropoietin (EPO) may also exert cytoprotective effects on non-erythroid tissues, including the brain, kidney, blood vessels, and pancreatic β cells. Recent reports have demonstrated the biological effects of EPO on the pancreatic β cells and its potential preventative and therapeutic role in diabetes. This review will focus on the emerging extra-hematopoietic roles of EPO and its potential protective role in diabetes.

Keywords: Angiogenesis, Apoptosis, Diabetes, Erythropoietin, Pancreatic beta cell, rHuEPO, Chronic hyperglycemia, Vascular complications, Euglycemia, Erythropoiesis

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [284 - 290]
Pages: 7
DOI: 10.2174/157339911796397820
Price: $65

Article Metrics

PDF: 12